Dave Lowrance
2018
In 2018, Dave Lowrance earned a total compensation of $2.2M as Chief Financial Officer & Secretary at Mast Therapeutics, a 459% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,891 |
|---|---|
| Option Awards | $1,671,362 |
| Salary | $365,000 |
| Other | $22,000 |
| Total | $2,175,253 |
Lowrance received $1.7M in option awards, accounting for 77% of the total pay in 2018.
Lowrance also received $116.9K in non-equity incentive plan, $365K in salary and $22K in other compensation.
Rankings
In 2018, Dave Lowrance's compensation ranked 5,291st out of 14,244 executives tracked by ExecPay. In other words, Lowrance earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,291 out of 14,244 | 63rd |
Division Manufacturing | 1,999 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 731 out of 2,128 | 66th |
Industry group Drugs | 611 out of 1,817 | 66th |
Industry Pharmaceutical Preparations | 471 out of 1,391 | 66th |
Pay ratio
| Dave Lowrance's Pay | $2,175,253 |
|---|---|
| Median Employee's Pay | $282,179 |
| Pay Ratio | 8to 1 |
In 2018, the annual total compensation of Dave Lowrance was $2,175,253.
The annual total compensation of the median employee at Mast Therapeutics was $282,179.
The ratio of Dave Lowrance's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 15, 2019.
Lowrance's colleagues
We found three more compensation records of executives who worked with Dave Lowrance at Mast Therapeutics in 2018.